223 related articles for article (PubMed ID: 17014384)
21. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
[TBL] [Abstract][Full Text] [Related]
22. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge.
Spadaro JA; Damron TA; Horton JA; Margulies BS; Murray GM; Clemente DA; Strauss JA
J Orthop Res; 2006 May; 24(5):936-44. PubMed ID: 16609966
[TBL] [Abstract][Full Text] [Related]
23. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
Zhou H; Shen V; Dempster DW; Lindsay R
J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
[TBL] [Abstract][Full Text] [Related]
24. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
25. Skeletal unloading alleviates the anabolic action of intermittent PTH(1-34) in mouse tibia in association with inhibition of PTH-induced increase in c-fos mRNA in bone marrow cells.
Tanaka S; Sakai A; Tanaka M; Otomo H; Okimoto N; Sakata T; Nakamura T
J Bone Miner Res; 2004 Nov; 19(11):1813-20. PubMed ID: 15476581
[TBL] [Abstract][Full Text] [Related]
26. Alendronate stimulation of nocturnal parathyroid hormone secretion: a mechanism to explain the continued improvement in bone mineral density accompanying alendronate therapy.
Greenspan SL; Holland S; Maitland-Ramsey L; Poku M; Freeman A; Yuan W; Kher U; Gertz B
Proc Assoc Am Physicians; 1996 May; 108(3):230-8. PubMed ID: 8774056
[TBL] [Abstract][Full Text] [Related]
27. The influence of combined parathyroid hormone and growth hormone treatment on cortical bone in aged ovariectomized rats.
Andreassen TT; Oxlund H
J Bone Miner Res; 2000 Nov; 15(11):2266-75. PubMed ID: 11092409
[TBL] [Abstract][Full Text] [Related]
28. Effects of treatment of ovariectomized adult rhesus monkeys with parathyroid hormone 1-84 for 16 months on trabecular and cortical bone structure and biomechanical properties of the proximal femur.
Fox J; Miller MA; Recker RR; Turner CH; Smith SY
Calcif Tissue Int; 2007 Jul; 81(1):53-63. PubMed ID: 17551766
[TBL] [Abstract][Full Text] [Related]
29. Alendronate administration and skeletal response during chronic alcohol intake in the adolescent male rat.
Wezeman FH; Emanuele MA; Moskal SF; Steiner J; Lapaglia N
J Bone Miner Res; 2000 Oct; 15(10):2033-41. PubMed ID: 11028458
[TBL] [Abstract][Full Text] [Related]
30. The anabolic effect of PTH on bone is attenuated by simultaneous glucocorticoid treatment.
Oxlund H; Ortoft G; Thomsen JS; Danielsen CC; Ejersted C; Andreassen TT
Bone; 2006 Aug; 39(2):244-52. PubMed ID: 16503210
[TBL] [Abstract][Full Text] [Related]
31. Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat.
Gasser JA; Ingold P; Venturiere A; Shen V; Green JR
J Bone Miner Res; 2008 Apr; 23(4):544-51. PubMed ID: 18072878
[TBL] [Abstract][Full Text] [Related]
32. Human parathyroid hormone (1-34) and (1-84) increase the mechanical strength and thickness of cortical bone in rats.
Ejersted C; Andreassen TT; Oxlund H; Jørgensen PH; Bak B; Häggblad J; Tørring O; Nilsson MH
J Bone Miner Res; 1993 Sep; 8(9):1097-101. PubMed ID: 8237479
[TBL] [Abstract][Full Text] [Related]
33. Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys.
Fox J; Miller MA; Newman MK; Recker RR; Turner CH; Smith SY
Bone; 2007 Sep; 41(3):321-30. PubMed ID: 17573250
[TBL] [Abstract][Full Text] [Related]
34. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ
J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
[TBL] [Abstract][Full Text] [Related]
35. Parathyroid hormone and mechanical usage have a synergistic effect in rat tibial diaphyseal cortical bone.
Ma Y; Jee WS; Yuan Z; Wei W; Chen H; Pun S; Liang H; Lin C
J Bone Miner Res; 1999 Mar; 14(3):439-48. PubMed ID: 10027909
[TBL] [Abstract][Full Text] [Related]
36. Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension.
Ensrud KE; Barrett-Connor EL; Schwartz A; Santora AC; Bauer DC; Suryawanshi S; Feldstein A; Haskell WL; Hochberg MC; Torner JC; Lombardi A; Black DM;
J Bone Miner Res; 2004 Aug; 19(8):1259-69. PubMed ID: 15231012
[TBL] [Abstract][Full Text] [Related]
37. Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice.
Kostenuik PJ; Bolon B; Morony S; Daris M; Geng Z; Carter C; Sheng J
Bone; 2004 Apr; 34(4):656-64. PubMed ID: 15050896
[TBL] [Abstract][Full Text] [Related]
38. Parathyroid hormone (1-34) increased total body bone mass in aged female rats.
Simmons HA; Pirie CM; Thompson DD; Ke HZ
J Pharmacol Exp Ther; 1998 Jul; 286(1):341-4. PubMed ID: 9655878
[TBL] [Abstract][Full Text] [Related]
39. Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women.
Kim JG; Kim JH; Lee DO; Kim H; Kim JY; Suh CS; Kim SH; Choi YM
Menopause; 2008; 15(2):357-62. PubMed ID: 17925661
[TBL] [Abstract][Full Text] [Related]
40. Dramatic increase in cortical thickness induced by femoral marrow ablation followed by a 3-month treatment with PTH in rats.
Zhang Q; Carlson J; Ke HZ; Li J; Kim M; Murphy K; Mehta N; Gilligan J; Vignery A
J Bone Miner Res; 2010 Jun; 25(6):1350-9. PubMed ID: 20200940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
